Table 2 Univariable logistic regression for AR
From: Androgen receptor expression and clinical significance in breast cancer
OR,95%CI | |||||
|---|---|---|---|---|---|
Clinical feature | P | OR | lower | upper | |
Histological grade | I | ||||
II | 0.729 | 1.304 | 0.290 | 5.865 | |
III | 0.333 | 2.111 | 0.465 | 9.583 | |
Molecular phenotype | TNBC | ||||
Luminal A | < 0.001 | 0.054 | 0.024 | 0.123 | |
Luminal B (HER2-) | < 0.001 | 0.072 | 0.035 | 0.149 | |
Luminal B (HER2+) | < 0.001 | 0.018 | 0.005 | 0.064 | |
HER2+ | < 0.001 | 0.113 | 0.045 | 0.280 | |
Vascular invasion | No | ||||
Yes | 0.597 | 0.871 | 0.523 | 1.452 | |
Neurology invasion | No | ||||
Yes | 0.317 | 0.672 | 0.308 | 1.464 | |
ER status | Negative | ||||
Positive | < 0.001 | 0.170 | 0.103 | 0.279 | |
PR status | Negative | ||||
Positive | < 0.001 | 0.206 | 0.127 | 0.335 | |
HER2 status | Negative | ||||
Positive | 0.010 | 0.441 | 0.236 | 0.825 | |
Ki-67 | < 20 | ||||
≥ 20 | 0.911 | 1.036 | 0.555 | 1.937 | |
EGFR status | Negative | ||||
Positive | < 0.001 | 7.610 | 3.967 | 14.600 | |